Literature DB >> 2562832

Insulin-receptor gene and its expression in patients with insulin resistance.

D Muller-Wieland1, R Taub, D S Tewari, K M Kriauciunas, S Sethu, K Reddy, C R Kahn.   

Abstract

We studied the structure of the insulin-receptor gene in normal individuals and in four unrelated patients with leprechaunism (Minn-1, Ark-1, Ark-2, Can-1) and four unrelated patients with the type A syndrome of insulin resistance, both disorders associated with genetic alterations in affinity, binding capacity, and kinase activity of the insulin receptor. Genomic cloning and Southern blot analysis indicate that the normal human insulin-receptor gene is greater than or equal to 150 kilobases long and consists of a minimum of 17 exons, 6 in the genomic region of the alpha-subunit and 11 in the region of the beta-subunit. Three of the patients, one with leprechaunism and two with type A syndrome, have decreases in insulin-receptor mRNA but on genomic blot analysis have no obvious abnormalities in the insulin-receptor gene. No distinctive pattern of restriction-fragment-length polymorphisms or evidence for major insertion or deletion mutations of the insulin-receptor gene was found in any of the patients. These data indicate that the insulin-receptor gene is greater than 35 times larger than coding regions and has a complex structure. Although leprechaunism and type A syndrome are most likely due to defects in the structure and expression of the insulin-receptor gene, they are likely to be associated with specific point mutations rather than major changes in gene structure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562832     DOI: 10.2337/diab.38.1.31

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  Severe insulin resistance alters metabolism in mesenchymal progenitor cells.

Authors:  Bharti Balhara; Alison Burkart; Vehap Topcu; Youn-Kyoung Lee; Chad Cowan; C Ronald Kahn; Mary-Elizabeth Patti
Journal:  Endocrinology       Date:  2015-03-26       Impact factor: 4.736

2.  Developmental programming: differential effects of prenatal testosterone excess on insulin target tissues.

Authors:  Shadia E Nada; Robert C Thompson; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2010-09-15       Impact factor: 4.736

3.  A nonsense mutation causing decreased levels of insulin receptor mRNA: detection by a simplified technique for direct sequencing of genomic DNA amplified by the polymerase chain reaction.

Authors:  T Kadowaki; H Kadowaki; S I Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  Reduced mRNA and a nonsense mutation in the insulin-receptor gene produce heritable severe insulin resistance.

Authors:  N Longo; S D Langley; L D Griffin; L J Elsas
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

5.  High inflammatory activity related to the number of metabolic syndrome components.

Authors:  Bahadir Kirilmaz; Fatih Asgun; Emin Alioglu; Ertugrul Ercan; Istemihan Tengiz; Ugur Turk; Serkan Saygi; Filiz Ozerkan
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-02-01       Impact factor: 3.738

Review 6.  Molecular genetics of severe insulin resistance.

Authors:  L J Elsas; N Longo; S Langley; L D Griffin; R C Shuster
Journal:  Yale J Biol Med       Date:  1989 Sep-Oct

7.  Genetic insulin resistance is a potent regulator of gene expression and proliferation in human iPS cells.

Authors:  Salvatore Iovino; Alison M Burkart; Kristina Kriauciunas; Laura Warren; Katelyn J Hughes; Michael Molla; Youn-Kyoung Lee; Mary-Elizabeth Patti; C Ronald Kahn
Journal:  Diabetes       Date:  2014-07-24       Impact factor: 9.461

Review 8.  Transcriptional Regulation of Glucose Metabolism: The Emerging Role of the HMGA1 Chromatin Factor.

Authors:  Eusebio Chiefari; Daniela P Foti; Riccardo Sgarra; Silvia Pegoraro; Biagio Arcidiacono; Francesco S Brunetti; Manfredi Greco; Guidalberto Manfioletti; Antonio Brunetti
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-03       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.